SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-010056
Filing Date
2019-07-02
Accepted
2019-07-01 17:32:34
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 433483
2 ex10-15.htm EX-10.15 59375
3 ex21-1.htm EX-21.1 2381
4 ex31-1.htm EX-31.1 18553
5 ex31-2.htm EX-31.2 18136
6 ex32-1.htm EX-32.1 6122
7 ex32-2.htm EX-32.2 6040
8 form10-k_001.jpg GRAPHIC 4256
9 form10-k_002.jpg GRAPHIC 1606
  Complete submission text file 0001493152-19-010056.txt   1651363

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE lwel-20190331.xml EX-101.INS 142915
11 XBRL SCHEMA FILE lwel-20190331.xsd EX-101.SCH 18148
12 XBRL CALCULATION FILE lwel-20190331_cal.xml EX-101.CAL 28278
13 XBRL DEFINITION FILE lwel-20190331_def.xml EX-101.DEF 55321
14 XBRL LABEL FILE lwel-20190331_lab.xml EX-101.LAB 127971
15 XBRL PRESENTATION FILE lwel-20190331_pre.xml EX-101.PRE 109010
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 1(781)728 0007
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 333-187874 | Film No.: 19934412
SIC: 2834 Pharmaceutical Preparations